{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "KRW", "exchange": "KSC", "shortName": "Yuhan", "longName": "Yuhan Corporation", "messageBoardId": "finmb_2444677", "exchangeTimezoneName": "Asia/Seoul", "exchangeTimezoneShortName": "KST", "gmtOffSetMilliseconds": 32400000, "market": "kr_market", "esgPopulated": false, "regularMarketChangePercent": -0.5244755, "regularMarketPrice": 56900.0, "marketState": "PREPRE", "fiftyTwoWeekHighChangePercent": -0.04369748, "fiftyTwoWeekLow": 49950.0, "fiftyTwoWeekHigh": 59500.0, "earningsTimestamp": 1682506740, "earningsTimestampStart": 1690369140, "earningsTimestampEnd": 1690804800, "epsCurrentYear": 1553.82, "priceEpsCurrentYear": 36.61943, "sharesOutstanding": 70402496, "fiftyDayAverage": 54110.0, "fiftyDayAverageChange": 2790.0, "fiftyDayAverageChangePercent": 0.051561635, "twoHundredDayAverage": 54211.953, "twoHundredDayAverageChange": 2688.0469, "twoHundredDayAverageChangePercent": 0.049584027, "marketCap": 4027023360000, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "averageAnalystRating": "1.8 - Buy", "tradeable": false, "cryptoTradeable": false, "priceHint": 2, "regularMarketChange": -300.0, "regularMarketTime": 1683873013, "regularMarketDayHigh": 57100.0, "regularMarketDayRange": "56000.0 - 57100.0", "regularMarketDayLow": 56000.0, "regularMarketVolume": 138043, "regularMarketPreviousClose": 57200.0, "bid": 56700.0, "ask": 56700.0, "fullExchangeName": "KSE", "financialCurrency": "KRW", "regularMarketOpen": 57100.0, "averageDailyVolume3Month": 177479, "averageDailyVolume10Day": 140916, "fiftyTwoWeekLowChange": 6950.0, "fiftyTwoWeekLowChangePercent": 0.13913915, "fiftyTwoWeekRange": "49950.0 - 59500.0", "fiftyTwoWeekHighChange": -2600.0, "firstTradeDateMilliseconds": 946944000000, "symbol": "000100.KS"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "74, Noryangjin-ro", "address2": "Daebang-dong Dongjak-gu", "city": "Seoul", "country": "South Korea", "phone": "82 2 828 0181", "fax": "82 2 828 0050", "website": "https://www.yuhan.co.kr", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Yuhan Corporation, a pharmaceutical company, engages in the research, development, and production of active pharmaceutical products and intermediates in South Korea and internationally. It offers antivirals, antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds; and Revanex, an acid pump antagonist for the treatment of peptic ulcers and gastritis-related mucosal injury. The company also provides ETC products, such as cardiovascular, alimentary, genito-urinary, metabolic, respiratory and allergy, and neuro systems, as well as anti-infective, anti-cancer, and hormone and other products; and analgesics, anti-rheumatics, and anesthetics. In addition, it offers over-the-counter (OTC) products, including vitamins and minerals, hepatopathy drugs and tonics, respiratory system drugs, alimentary system drugs, dermatology and analgesics drugs, and others; and household and healthcare products, such as bleaches, detergents, pesticides, and oral care products. Further, the company engages in dental business and provides implants, dental equipment/consumable, and dental care products. Additionally, the company manufactures and sells medical supplies for livestock, aquatic animals, and companion animals; and provides contract manufacturing services. Yuhan Corporation was founded in 1926 and is headquartered in Seoul, South Korea.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Wook-Je  Cho", "age": 67, "title": "Pres, CEO & Exec. Director", "yearBorn": 1955, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jae-Kyo  Kim", "age": 55, "title": "Exec. Vice Director & Head of the Pharmaceutical Bus. Mgnt. Dept.", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Byung-Man  Lee", "age": 64, "title": "Exec. VP, Head of the Pharmaceutical Bus. Division & Exec. Director", "yearBorn": 1958, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 5, "boardRisk": 9, "compensationRisk": 1, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1682899200, "maxAge": 86400}}], "error": null}}